- $1.46bn
- $1.93bn
- $3.11bn
- 46
- 68
- 59
- 59
Annual income statement for PACS, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 1,167 | 2,422 | 3,111 |
Cost of Revenue | |||
Gross Profit | 265 | 561 | 664 |
Selling / General / Administrative Expenses | |||
Depreciation and Amortization | |||
Total Operating Expenses | 1,083 | 2,193 | 2,904 |
Operating Profit | 83.4 | 229 | 208 |
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | 81.4 | 207 | 157 |
Provision for Income Taxes | |||
Net Income After Taxes | 47.9 | 150 | 113 |
Minority Interest | |||
Net Income Before Extraordinary Items | |||
Net Income | 47.9 | 150 | 113 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | 47.9 | 150 | 113 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | 0.324 | 1.02 | 0.764 |